Bethany Sensenig

SUPN

Bethany Sensenig serves as Director at Supernus Pharmaceuticals, Inc. (SUPN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$455.1K

Net Position

Net Seller

$455.1K

Companies Traded

SUPN

Active Period

Aug 2025 – Feb 2026

2 total trades

Most Recent

Sell SUPN

Feb 19, 2026 · $228.3K

Bethany Sensenig's Insider Trading at Supernus Pharmaceuticals, Inc. (SUPN)

Buys

0 · $0.00

Sells

2 · $455.1K

Total Shares Bought

Total Shares Sold

9,844

SUPN Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 19, 2026	Sell	4,475	$51.01	$228.3K	0
Aug 14, 2025	Sell	5,369	$42.25	$226.8K	0

Related Insiders

Padmanabh P. Bhatt

Sr. VP of IP, CSO

SUPNSell · Mar 18, 2026

Frederick M. Hudson

Director

SUPNSell · Mar 16, 2026

Jack A. Khattar

President, CEO

SUPNSell · Mar 16, 2026

William Todd Horich

officer: SVP, Commercial Operations

SUPNSell · Mar 10, 2026

Frank Mottola

SVP, Quality, GMP, Ops, IT

SUPNSell · Mar 10, 2026

GEMAYEL GEORGES

director

SUPNSell · Mar 9, 2026

NEWHALL CHARLES W III

Director

SUPNSell · Oct 9, 2025

Jonathan Rubin

SVP, Chief Medical Officer

SUPNSell · Sep 25, 2025

Explore More Insider Trading Data

SUPN Insider Trading Activity

View all insider trades at Supernus Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity